Troubled recall of Philips CPAP machines; Neuralink brain-machine interface nears human studies

The recall of millions of CPAP machines and other breathing devices made by Philips underscores critical shortcomings of device oversight. ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ 

'A constant information lag': The troubled recall of Philips CPAP machines underscores flaws in device oversight By Brittany Trang Adobe The recall of millions of CPAP machines and other breathing devices made by Philips underscores critical shortcomings of device oversight. Read More Elon Musk says Neuralink's brain-machine interface could enter human studies next year By Mohana Ravindranath and Katie Palmer Adobe Elon Musk said Wednesday that his brain-machine interface company Neuralink aims to put its first implant in a human subject in the next six months. Read More STAT+: With early data and a possible advantage, Amgen enters the obesity drug race  By Jason Mast Ric Francis/AP Amgen's candidate works similarly to Lilly and Novo drugs, but with a twist that could induce greater, longer-lasting weight loss. Read More Sponsored Insight by STAT Reports The potential for mRNA to transform the drug industry could extend well beyond its usefulness in infectious disease immunization vaccines mRNA is powering the next generation of gene editing technologies. Think of this STAT exclusive report as an introduction to a large, active, and fast-growing field. We'll delve into how researchers are working to harness mRNA in fighting cancer, replenishing missing proteins, and even rewriting our DNA, among other areas. By the end you should have a good grasp of where the field is and where it's going. Download the report here. 'This actually changes everything': Altered image in 1999 paper raises potential peril for Stanford president By Olivia Goldhill and Megan Molteni Adam Fagen The altered images in a 1999 paper co-authored by Stanford president Marc Tessier-Lavigne appear to be intentional, according to experts. Read More STAT+: Afraid of pharma pushback, a health data broker puts up a barrier to drug pricing information By Ed Silverman and Casey Ross Adobe Merative, which was formed using assets from IBM Watson Health, will no longer provide the media with information on drug pricing changes. Read More STAT+: Roche's failed Alzheimer's studies lend weight to an emerging idea about potential treatments By Damian Garde and Jonathan Wosen Adobe Some researchers concluded that investigational medicines might need to clear out substantial amounts of amyloid in order to show a benefit. Read More Opinion: The U.S. doesn't need a new 'essential hospital' designation By Elise Amez-Droz Adobe A call to create a new "essential hospitals" designation would do little to improve the quality or cost of care in the U.S. Read More Abortion rights groups look to next fights after 2022 wins By Sara Burnett — Associated Press Meg Kinnard/AP Emboldened by the results of November's midterms, abortion rights supporters are preparing for even bigger fights ahead. Read More Thursday, December 1, 2022       1 Exchange Pl, Suite 201, Boston, MA 02109 ©2022, All Rights Reserved. I no longer wish to receive STAT emails Update Email Preferences | Contact Us | View In Browser